Historical record - last NADAC effective date: 9/18/2024
Product Information
HYDROCODONE ER 10 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $6.3579 per EA under NDC 47781040960. Its NADAC has been published 125 times since Feb 17, 2021.
FDA first approved this application on Jan 21, 2020.
Strength
10 mg/1
Manufacturer
Alvogen Inc.NDC
47781040960
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/18/2024
Active Ingredients
HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA206986FDA Approved
1/21/2020
On Market Since
1/21/2020
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE ER 10 MG CAPSULE has been published 125 times since Feb 17, 2021, and over the history we have for it it has declined 13.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3579 per EA |
|---|---|
| All-time high | $7.3759 (Feb 16, 2022) |
| All-time low | $6.3510 (Apr 17, 2024) |
| Median price | $6.4220 |
| Average price | $6.8030 |
| Largest weekly change | -13.9% (Apr 17, 2024) |
| Weeks tracked | 125 |
| Tracking since | Feb 17, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-13.8%
5Y
-13.8%
All
-13.8%
Last surveyed Aug 27, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocodone Bitartrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alvogen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE ER 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE ER 10 MG CAPSULE, manufactured by Alvogen Inc., is $6.3579 per EA (NDC 47781040960), effective Aug 27, 2025.
How has the price of HYDROCODONE ER 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for HYDROCODONE ER 10 MG CAPSULE has declined 13.8%. It has been tracked across 125 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for HYDROCODONE ER 10 MG CAPSULE?
Since Feb 17, 2021, the NADAC for HYDROCODONE ER 10 MG CAPSULE has ranged from a low of $6.3510 (Apr 17, 2024) to a high of $7.3759 (Feb 16, 2022), with a median of $6.4220 per EA.
Are there cheaper alternatives to HYDROCODONE ER 10 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCODONE ER 10 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCODONE ER 10 MG CAPSULE?
HYDROCODONE ER 10 MG CAPSULE (NDC 47781040960) is labeled by Alvogen Inc., and CMS classifies it as a generic product.